Judicial Panel Consolidated Spinal Cord Stimulator Lawsuits
The federal panel ordered separate multidistrict litigation for Abbott and Nevro device claims.
Updated on Oct. 8, 2026 in Healthcare
Live Poll
Should courts consolidate individual product liability lawsuits into large multidistrict litigation cases?
The Judicial Panel on Multidistrict Litigation has ordered the consolidation of lawsuits alleging defective spinal cord stimulators. The ruling establishes separate multidistrict litigation dockets for cases involving Abbott Laboratories and Nevro LLC.
Why it matters
The consolidation signals a shift in how these liability claims will be managed, centralizing discovery and pretrial proceedings for potentially large volumes of litigation against these manufacturers. It forces operators in the medical device sector to prepare for intensified regulatory and legal oversight regarding device safety.
The Judicial Panel on Multidistrict Litigation established two distinct MDL dockets for Abbott Laboratories and Nevro LLC. The exact total number of pending lawsuits subject to these new dockets is currently unknown.
The players
Abbott Laboratories
A global healthcare company with a large portfolio of medical devices and diagnostic systems.
Nevro LLC
A medical device company specializing in spinal cord stimulation technology for chronic pain treatment.
Judicial Panel on Multidistrict Litigation
A federal body that oversees the consolidation and management of complex lawsuits across U.S. district courts.
The details
The federal panel dismissed arguments from both manufacturers that the cases lacked sufficient common factual questions to warrant grouping. By consolidating these actions, the court will streamline pretrial motions and evidence discovery, effectively centralizing legal efforts against the specific spinal cord stimulator models. Operators should note that this process limits the geographic dispersion of legal proceedings.
Timeline
October 7, 2026: The Judicial Panel on Multidistrict Litigation issued the consolidation order.
Market Landscape
This move mirrors the procedural pattern set by the 2011 In re: Medtronic, Inc., Sprint Fidelis Leads Products Liability Litigation, which centralized claims regarding common device failures. The ruling marks a significant escalation in how federal courts manage liability for medical technology producers.
Medical device businesses should anticipate increased scrutiny during future product liability filings now that federal dockets have been consolidated. Manufacturers should audit their documentation procedures to prepare for standardized, high-volume pretrial discovery processes.
The takeaway
Centralized federal dockets often lead to faster discovery cycles and higher stakes for corporate legal teams. Keep a close watch on future case management orders issued by the district courts assigned to oversee these specific Abbott and Nevro dockets.
Further reading
For more on the industry's regulatory environment, explore the latest updates in Healthcare.
Source note: This article includes information reported by Law360.
Live Poll
Should courts consolidate individual product liability lawsuits into large multidistrict litigation cases?
